Correlation Between Thayer Ventures and Dermata Therapeutics
Can any of the company-specific risk be diversified away by investing in both Thayer Ventures and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Thayer Ventures and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Thayer Ventures Acquisition and Dermata Therapeutics Warrant, you can compare the effects of market volatilities on Thayer Ventures and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Thayer Ventures with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Thayer Ventures and Dermata Therapeutics.
Diversification Opportunities for Thayer Ventures and Dermata Therapeutics
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Thayer and Dermata is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Thayer Ventures Acquisition and Dermata Therapeutics Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Thayer Ventures is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Thayer Ventures Acquisition are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Thayer Ventures i.e., Thayer Ventures and Dermata Therapeutics go up and down completely randomly.
Pair Corralation between Thayer Ventures and Dermata Therapeutics
Assuming the 90 days horizon Thayer Ventures is expected to generate 27.29 times less return on investment than Dermata Therapeutics. But when comparing it to its historical volatility, Thayer Ventures Acquisition is 11.26 times less risky than Dermata Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Dermata Therapeutics Warrant is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 0.81 in Dermata Therapeutics Warrant on September 1, 2024 and sell it today you would earn a total of 0.07 from holding Dermata Therapeutics Warrant or generate 8.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 42.06% |
| Values | Daily Returns |
Thayer Ventures Acquisition vs. Dermata Therapeutics Warrant
Performance |
| Timeline |
| Thayer Ventures Acqu |
| Dermata Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
Thayer Ventures and Dermata Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Thayer Ventures and Dermata Therapeutics
The main advantage of trading using opposite Thayer Ventures and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Thayer Ventures position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.| Thayer Ventures vs. Inspirato | Thayer Ventures vs. Anghami De | Thayer Ventures vs. Cepton Inc | Thayer Ventures vs. Cepton Inc |
| Dermata Therapeutics vs. Tff Pharmaceuticals | Dermata Therapeutics vs. Eliem Therapeutics | Dermata Therapeutics vs. Inhibrx | Dermata Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |